Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.3 - AXA INVESTMENT MANAGERS: PRS REIT Plc
-
BULGOLD Commences Drilling on the Lutila Gold Project
-
Celestica Announces TSX Acceptance of Normal Course Issuer Bid
-
HII Reports Third Quarter 2025 Results
-
Iceland Seafood International hf: Q3 2025 results and investors presentation
-
Quantum Solutions Becomes Asia’s Largest Institutional ETH Holder with Backing from ARK Invest’s Cathie Wood
-
Onex Announces Transformational Investment and New Strategic Relationship to Drive Enterprise Growth and Shareholder Value
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidn
-
Zhihu Inc. to Report Third Quarter 2025 Financial Results on November 25, 2025
-
Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
PST Group to Build Rheinmetall Factory in Baisogala
-
Man Group PLC : Form 8.3 - Spectris plc
-
MADD Canada Kicks Off 38th Project Red Ribbon National Campaign to Prevent Impaired Driving this Holiday Season
-
Halcones Precious Metals Announces Commencement of Legal Process to Secure Surface Access to Polaris Project, Chile
-
Studio City Announces Earnings Release Date
-
Trifork Group: Completion of 51.0% divestment of Trifork Security
-
Premier American Uranium Announces Preliminary Economic Assessment and Mineral Resource Update for the Cebolleta Uranium Project, Outlining Project Economics and Framework for Enhancement
-
HPQ Receives First Industrial Shipments of HPQ ENDURA+ Batteries
-
LKQ Corporation Announces Results for Third Quarter 2025
-
Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company’s Board of Directors
-
Aldebaran PEA for the Altar Project Reports 48 Year Mine Life, After Tax NPV (8%) of US$2 Billion, and 20.5% IRR
-
Sprott Announces Date for 2025 Third Quarter Results Webcast
-
MAX Power Appoints Energy Leader as New CEO to Drive Next Phase of Natural Hydrogen Growth
-
Abercrombie & Fitch and Luxury Retailer Kemo Sabe Debut Western-Inspired Collaboration
-
Forward Therapeutics Announces First Participants Dosed in Phase 1 Healthy Volunteer Study of FT2109, a Next-Generation TNF Signaling Inhibitor
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
-
Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025
-
Axi Attends iFX Expo Asia 2025, Showcases its Products and Services
-
CropLife Canada Urges Bold Action to Unlock Agricultural Productivity Growth and Strengthen the Economy
-
Broadwind Announces Third Quarter 2025 Results Conference Call and Webcast Date
-
Inflection Resources Outlines Large-Scale Copper-Gold Targets on the Endurance Projects, Northern Territory, Australia
-
AmpliTech Group Announces Unit Rights Offering
-
Alta Equipment Group Announces Date of Third Quarter 2025 Financial Results Release, Conference Call and Webcast
-
Autolus Therapeutics to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
-
Troilus Wins “Entrepreneur of the Year” Award From the Québec Mineral Exploration Association, Recognizing Leadership in Advancing One of Canada’s Largest Copper-Gold Projects
-
MEXC Debuts at Bolivia Blockchain Week 2025, Honored with LATAM Blockchain Award
-
Wrap and Mithril Defense Achieve Historic First Drone-to-Human Interdiction, Proving Next-Gen Non-Lethal Aerial Response for Public Safety and Defense
-
ConnectOne Bancorp, Inc. Reports Third Quarter 2025 Results
-
Talisker Signs Binding Terms for an Ore Purchase Agreement with Ocean Partners for up to 1,500 tpd
-
Amplify ETFs Declares October Income Distributions for its Income ETFs
-
Bitdeer Announces Third Quarter 2025 Earnings Conference Call for November 10, 2025
-
Wellchange Holdings Company Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
-
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Aduro Clean Technologies Provides Update on NGP Pilot Plant Commissioning
-
Gain Therapeutics to Present at Neuroscience 2025
-
iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
-
Abercrombie & Fitch and Luxury Retailer Kemo Sabe Debut Western-Inspired Collaboration
